Frankfurt - Delayed Quote EUR
Q32 Bio Inc. (DB0.F)
1.5600
-0.0500
(-3.11%)
At close: April 25 at 3:49:30 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALLOWAY PAUL President | Conversion of Exercise of derivative security | Mar 25, 2024 | 51,566 |
| CAMPAGNA JASON Officer | Stock Award(Grant) | Feb 24, 2025 | 37,500 |
| JORDAN JULIE Officer | Conversion of Exercise of derivative security | Aug 3, 2023 | 7,496 |
| KALOWSKI LEE Chief Executive Officer | Stock Award(Grant) | Feb 24, 2025 | 53,250 |
| MICHAUD CHARLES JR. Officer and Treasurer | Conversion of Exercise of derivative security | Mar 25, 2024 | 18,046 |
| MORRISON JODIE POPE Chief Executive Officer | Stock Award(Grant) | Feb 24, 2025 | 132,000 |
| SEYMOUR ALBERT B Chief Executive Officer | Conversion of Exercise of derivative security | Sep 6, 2023 | 150,874 |
| TZIANABOS ARTHUR Director | Conversion of Exercise of derivative security | Mar 25, 2024 | 7,983 |
| VIOLETTE SHELIA M PH.D. Officer | Stock Award(Grant) | Feb 24, 2025 | 97,651 |
Related Tickers
2509.HK Qyuns Therapeutics Co., Ltd.
10.960
+3.59%
CLYM Climb Bio, Inc.
1.2700
-2.31%
EQ Equillium, Inc.
0.4382
-4.74%
HNSA.ST Hansa Biopharma AB (publ)
28.36
+19.76%
TVRD Tvardi Therapeutics, Inc.
18.85
+5.90%
SAGE Sage Therapeutics, Inc.
7.79
0.00%
FOLD Amicus Therapeutics, Inc.
7.35
+2.08%
AVTE Aerovate Therapeutics, Inc.
2.6800
-1.47%
XFOR X4 Pharmaceuticals, Inc.
0.1900
+1.50%
ONC BeiGene, Ltd.
244.90
-4.40%